← Back to Search

Behavioral Intervention

High-Intensity Interval Training for Stroke (HST2 Trial)

N/A
Recruiting
Led By Pierce Boyne, PT, DPT, PhD
Research Sponsored by University of Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Able to walk at least 3 minutes on the treadmill at ≥0.13m/s (0.3 mph)
Stable cardiovascular condition (AHA class B, allowing for aerobic capacity <6 metabolic equivalents)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 3 month follow up
Awards & highlights

HST2 Trial Summary

This trial will study stroke survivors who still have trouble walking. They will be randomly placed in either a moderate or vigorous walking exercise group. The exercises will be done with a physical therapist for 45 minutes

Who is the study for?
This trial is for individuals who had a stroke at least 6 months ago and are experiencing walking difficulties. They should be able to participate in physical therapy sessions three times a week for 12 weeks, with follow-up assessments.Check my eligibility
What is being tested?
The HIT-Stroke Trial 2 is testing the effectiveness of two types of exercise: High-Intensity Interval Training (HIIT) versus Moderate-Intensity Aerobic Training (MIAT), on improving walking function after a stroke.See study design
What are the potential side effects?
Potential side effects from the exercises may include muscle soreness, fatigue, and increased heart rate during training. However, these are common reactions to physical activity and will be monitored by therapists.

HST2 Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can walk on a treadmill for at least 3 minutes at a slow pace.
Select...
My heart condition is stable but I have limited exercise ability.
Select...
I have weakness on one side of my body due to a stroke.
Select...
My walking speed is less than 1 meter per second.
Select...
I can walk 10 meters by myself, but I can use help like a cane or walker if needed.
Select...
I can understand and follow instructions and answer questions about the study.
Select...
I am between 30 and 85 years old.

HST2 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 3 month follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 3 month follow up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
6-Minute Walk Test Distance
Aerobic Capacity
EuroQol-5D-5L
+3 more

HST2 Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: High-Intensity Interval TrainingExperimental Treatment1 Intervention
Group II: Moderate-Intensity Aerobic TrainingActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
High-Intensity Interval Training
2019
N/A
~570

Find a Location

Who is running the clinical trial?

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,965 Previous Clinical Trials
2,672,641 Total Patients Enrolled
79 Trials studying Stroke
5,231 Patients Enrolled for Stroke
University of Kansas Medical CenterOTHER
463 Previous Clinical Trials
169,114 Total Patients Enrolled
8 Trials studying Stroke
527 Patients Enrolled for Stroke
University of CincinnatiLead Sponsor
428 Previous Clinical Trials
634,238 Total Patients Enrolled
31 Trials studying Stroke
16,068 Patients Enrolled for Stroke

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the clinical trial enrolling participants who are older than 85 years of age?

"Individuals seeking to participate in this research must be between 30 and 85 years old to meet the age requirements for enrollment."

Answered by AI

Do I meet the necessary requirements to participate in this clinical investigation?

"Individuals aged between 30 and 85 who have experienced a stroke are eligible to participate in this research endeavor, which aims to enroll 156 participants."

Answered by AI

Is the enrollment process currently open for this ongoing medical study?

"As per the information provided on clinicaltrials.gov, this trial is currently in active patient recruitment. It was initially posted on February 9th, 2024 and last modified on February 12th, 2024."

Answered by AI
~104 spots leftby Jan 2028